Heritas Capital co-leads Hummingbird Bioscience’s extended Series A

Antibody visual sourced from Hummingbird's website

Biotech company Hummingbird Bioscience has announced the completion of an extended Series A funding round led by Singapore-based Heritas Capital Management and SEEDS Capital, the investment arm of Enterprise Singapore.

Existing backer and Series A lead investor Decheng Capital also participated in the latest financing.

Hummingbird focuses on the discovery and development of novel antibody-based therapeutics. The biotech firm will use the fresh capital infusion to advance is anti-VISTA and anti-HER3 programs to first-in-human clinical trials. The company will also expand its laboratory facilities.

“Hummingbird’s computational biology-driven drug discovery platform, which has since yielded two high-potential pre-clinical stage drug compounds, represents early inroads of Singapore’s investments into biopharmaceutical R&D,” said SEEDS Capital general manager Geoffrey Yeo.

As part of the financing, Heritas Capital Management CEO and executive director Chik Wai Chiew and Decheng Capital partner Victor Tong will join the Hummingbird board. Heritas, a private equity and venture capital investor based in Singapore, made the investment through the Heritas Venture Fund.

The company had received a $13.1-million product development grant in February from the Cancer Prevention and Research Institute of Texas. The grant will support clinical trials of its anti-VISTA antibody for the treatment of solid tumours and lymphomas unresponsive to existing therapies.

Hummingbird has operating locations in Houston, Texas; South San Fransisco, California; as well as Singapore.

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.